MedTech Dive November 30, 2022
Maria Pereira, co-founder and chief innovation officer of Paris-based Tissium, was a PhD student in bioengineering at the Massachusetts Institute of Technology when a surgeon asked her lab team if it could come up with a new treatment for ventricular septal defect, a hole in the wall that separates the heart’s lower chambers. From that challenge over a decade ago evolved a medtech startup with 97 employees that is currently developing a family of polymers to address multiple unmet clinical needs in tissue reconstruction. Tissium aims in the next two years to bring to market its first product, a polymer technology that offers a sutureless way to repair peripheral nerves.
The company, which changed its name from Gekko Biomedical to...
Today's Sponsors
Today's Sponsor